日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Highly specific intracellular ubiquitination of a small molecule.

小分子的高度特异性细胞内泛素化。

Li Weicheng, Garcia-Rivera Enrique M, Mitchell Dylan C, Chick Joel M, Maetani Micah, Bhadoria Rohit, Knapp John M, Misu Ryosuke, Matthews Geoffrey M, Shirasaki Ryosuke, de Matos Simoes Ricardo, Viswanathan Vasanthi, Pulice John L, Rees Matthew G, Roth Jennifer A, Gygi Steven P, Mitsiades Constantine S, Kadoch Cigall, Schreiber Stuart L, Ostrem Jonathan M L

Management of hematological toxicities after BCMA-directed CAR-T cell therapy

BCMA靶向CAR-T细胞疗法后血液学毒性的管理

Cook, Joselle; Gupta, Supriya; Abdallah, Nadine; Rees, Matthew; Graham, Christopher; Ng, Lay She; Bansal, Radhika; De Menezes Silva Corraes, Andre; Helms, Kristina; Warsame, Rahma; Dingli, David; Gonsalves, Wilson; Kourelis, Taxiarchis; Gertz, Morie; Hayman, Suzanne; Leung, Nelson; Kapoor, Prashant; Hwa, Lisa; Fonder, Amie; Hobbs, Miriam; Bergsagel, Leif; Yadav, Udit; Wiedmeier-Nutor, Erin; Chhabra, Saurabh; Fonseca, Rafael; Ailawadhi, Sikander; Parrondo, Ricardo; Kumar, Shaji; Lin, Yi

Proximity-Induced Rewiring of Oncogenic Kinase Triggers Apoptosis

邻近诱导的致癌激酶重编程触发细胞凋亡

Merz, Manuel L; Shoba, Veronika M; Pergu, Rajaiah; Severance, Zachary C; Munkanatta Godage, Dhanushka N P; Deb, Arghya; Kwok, Hui Si; Singh, Prashant; Singh, Sameek; Allen, Jonathan B; Tian, Wenzhi; Gosavi, Pallavi M; Chaudhary, Santosh K; Anokhina, Viktoriya; Weisberg, Ellen L; Payne, N Connor; He, Yao; Dhaliwal, Rohil; Osadchey, Reilly; Shekhar, Mrinal; Mazitschek, Ralph; Rees, Matthew G; Roth, Jennifer A; Cui, Qiang; Griffin, James D; Liau, Brian B; Choudhary, Amit

PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models.

PI3Kα抑制剂和降解剂Inavolisib可利用FGFR2增强PIK3CA突变实体瘤患者和临床前模型的疗效。

Juric Dejan, Song Kyung, Johnson Radia M, Accordino Melissa K, Bedard Philippe L, Cervantes Andrés, Gambardella Valentina, Hamilton Erika, Italiano Antoine, Kalinsky Kevin, Krop Ian E, Oliveira Mafalda, Saura Cristina, Schmid Peter, Turner Nicholas C, Varga Andreea, Gendreau Steven, Hwang Michael S, Kuang Zheng, Lau Jeffrey T, Lin Eva, Pham Trang, Maddalo Danilo, Rees Matthew G, Ronan Melissa M, Roth Jennifer A, Martin Scott, Sodir Nicole M, Sokol Ethan S, Whitfield Zachary J, Wong Alice, Yauch Robert L, Aimi Junko, Cheeti Sravanthi, Fredrickson Jill, Hilz Stephanie, Hafner Marc, Hutchinson Katherine E, Jin Yanling, Peters Ubong, Zingg Daniel, Royer-Joo Stephanie, Shankar Noopur, Schutzman Jennifer L, Jhaveri Komal L, Dey Anwesha

Proteomic shifts post-plasma cell therapy in AL amyloid plaques and potential implications for light chaindirected anti-fibril monoclonal antibodies

AL淀粉样斑块经浆细胞治疗后蛋白质组的变化及其对轻链导向抗原纤维单克隆抗体的潜在影响

Rees, Matthew J; Dasari, Surendra; McPhail, Ellen D; Dispenzieri, Angela; Charlesworth, Cristine M; Muchtar, Eli; Gertz, Morie; Gupta, Navin; Anderson, Emilie; Quang, Samantha N; Dick, Christopher; Kumar, Shaji; Kourelis, Taxiarchis

Asparaginase-associated pancreatitis during therapy for pediatric acute lymphoblastic leukemia

儿童急性淋巴细胞白血病治疗期间发生的门冬酰胺酶相关性胰腺炎

McCarville, M Beth; Ashcraft, Emily; Ribeiro, Raul C; Rees, Matthew; Swanson, Hope D; Inaba, Hiroto; Jeha, Sima; Cheng, Cheng; Pui, Ching-Hon; Karol, Seth E

Response to Comment on: "Hepatitis B virus reactivation following T-cell engager therapy in multiple myeloma despite negative hepatitis B core antibody serology: implications for screening in patients with hematological malignancies"

对以下评论的回应:“尽管乙型肝炎核心抗体血清学检测呈阴性,但多发性骨髓瘤患者接受T细胞衔接器治疗后仍出现乙型肝炎病毒再激活:对血液系统恶性肿瘤患者筛查的启示”

Rees, Matthew J; Quach, Hang; Jardine, Darren; Thompson, Alexander

Synthesis and Biological Evaluation of Colibactin Derivatives

大肠杆菌素衍生物的合成及生物学评价

Airan, Yougant; Fedorova, Olga; Heer, Collin; Rees, Matthew G; Ronan, Melissa M; Roth, Jennifer A; Bindra, Ranjit S; Herzon, Seth B

KDM4C inhibition blocks tumor growth in basal breast cancer by promoting cathepsin L-mediated histone H3 cleavage.

KDM4C 抑制剂通过促进组织蛋白酶 L 介导的组蛋白 H3 裂解来阻断基底型乳腺癌的肿瘤生长

Li Zheqi, Peluffo Guillermo, Stevens Laura E, Qiu Xintao, Seehawer Marco, Tawawalla Amatullah, Huang Xiao-Yun, Egri Shawn B, Raval Shaunak, McFadden Maeve, D'Santos Clive S, Papachristou Eva, Kingston Natalie L, Nishida Jun, Evans Kyle E, Seo Ji-Heui, Clement Kendell, Temko Daniel, Ekram Muhammad, Li Rong, Rees Matthew G, Ronan Melissa M, Roth Jennifer A, Simeonov Anton, Kales Stephen C, Rai Ganesha, Lal-Nag Madhu, Maloney David J, Jadhav Ajit, Michor Franziska, Meissner Alex, Balko Justin M, Carroll Jason S, Freedman Matthew L, Jaffe Jacob D, Papanastasiou Malvina, Long Henry W, Polyak Kornelia

Identification of a Selective Anticancer Agent from a Collection of Complex-And-Diverse Compounds Synthesized from Stevioside

从甜菊苷合成的一系列复杂多样的化合物中鉴定出一种选择性抗癌剂

Schaaf, Rachel E; Quirke, Jonathan C K; Ghavami, Maryam; Tonogai, Emily J; Lee, Hyang Yeon; Barlock, Samantha L; Trzupek, Thomas R; Abo, Kyle R; Rees, Matthew G; Ronan, Melissa M; Roth, Jennifer A; Hergenrother, Paul J